- Report
- July 2024
- 136 Pages
Europe
From €1363EUR$1,500USD£1,171GBP
- Report
- July 2024
- 136 Pages
Asia Pacific
From €1363EUR$1,500USD£1,171GBP
- Report
- July 2024
- 120 Pages
North America
From €1363EUR$1,500USD£1,171GBP
- Report
- July 2024
- 136 Pages
Middle East, Africa
From €1363EUR$1,500USD£1,171GBP
- Report
- February 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- July 2023
- 82 Pages
Global
From €3500EUR$4,126USD£3,113GBP
The Feline Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for cats. Vaccines are used to protect cats from a variety of diseases, including feline leukemia, rabies, and feline infectious peritonitis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal.
The Feline Vaccine market is highly competitive, with a number of companies offering a wide range of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Animal Health. These companies offer a variety of vaccines, including those for feline leukemia, rabies, and feline infectious peritonitis. Show Less Read more